Sean Toomey, MD
Orthopaedic Surgery · Seattle, WANPI 1003876343
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,017,202 of the $1,185,645 with a category attached, or 85.8%. Stryker accounts for 99.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $286,548 and has fallen 67.1% since, to $94,154 in 2025. Among orthopaedic surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,036 payments — averaging $1144.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.2M
- Davol Inc.$514
- BD$164
- Johnson & Johnson$121
- Medacta USA, Inc.$59
- Tersera Therapeutics LLC$32
- plus $18 from 1 others
Across 14 payments — averaging $6625.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$93K
What the payments were for
- Consulting fees$1,017,20286%
- Travel & lodging$143,01312%
- Food & beverage$25,4312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1,027 | $1,184,736 |
| Davol Inc. | 3 | $514 |
| BD | 1 | $164 |
| Johnson & Johnson(2 entities) | 2 | $121 |
| Medacta USA, Inc. | 1 | $59 |
| Tersera Therapeutics LLC | 1 | $32 |
| Radius Health, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,108,637
- TRIATHLON$47,451
- INSIGNIA$38,751
- EXETER$35,546
- ACCOLADE$26,274
- TRIDENT$21,692
- RESTORATION$20,750
- Verasense$3,960
- BIOLOX$3,945
- MOTIONSENSE DIGITAL GONIOMETER$3,000
- NONE$2,500
- GMRS$2,250
- TRITANIUM$500
- ARISTA$247
- RIO$216
- ARISTA AH FLEXITIP$164
- NASOPORE$156
- Viaflow$142
- INBONE$142
- AUGMENT INJECTABLE$142
How this compares
$1,185,645 in reported general payments places this provider in the 95th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin | 80 | $120 |
| Cephalexin | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Seattle
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Burt YaszaySeattle$1.3M
- Robert HartSeattle$942K
- Jeffrey RohSeattle$604K
- Michael BrageSeattle$496K
- Daniel SchwartzSeattle$424K
- Grant GarciaSeattle$367K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.